drugset / Trial / NCT00652496
Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
This study evaluates the safety and efficacy of different formulations of bimatoprost ophthalmic solution compared with Bimatoprost 0.03% once-daily in patients with glaucoma or ocular hypertension. One of the test formulations was given to one eye and bimatoprost 0.03% given to the fellow eye of each patient
Timeline
- Start
- 2005-01
- Primary completion
- 2005-05
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bimatoprost | Other / unclassified | 0.01 % | Other |
| Subject | Bimatoprost | Other / unclassified | 0.015 % | Other |
| Subject | Bimatoprost | Other / unclassified | 0.02 % | Other |
| Subject | Bimatoprost | Other / unclassified | 0.03 % | Other |